Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review.
Lidia GattoEnrico FranceschiAlicia TosoniVincenzo Di NunnoIlaria MaggioCaterina TononRaffaele LodiRaffaele AgatiStefania BartoliniAlba Ariela BrandesPublished in: Clinical case reports (2021)
Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1-weighted images and a simultaneous hyperintensity on T2-weighted or fluid-attenuated inversion recovery images.